193 related articles for article (PubMed ID: 31255796)
1. Development and Clinical Validation of a Large Fusion Gene Panel for Pediatric Cancers.
Chang F; Lin F; Cao K; Surrey LF; Aplenc R; Bagatell R; Resnick AC; Santi M; Storm PB; Tasian SK; Waanders AJ; Hunger SP; Li MM
J Mol Diagn; 2019 Sep; 21(5):873-883. PubMed ID: 31255796
[TBL] [Abstract][Full Text] [Related]
2. Feasibility and clinical utility of a pan-solid tumor targeted RNA fusion panel: A single center experience.
Hindi I; Shen G; Tan Q; Cotzia P; Snuderl M; Feng X; Jour G
Exp Mol Pathol; 2020 Jun; 114():104403. PubMed ID: 32061944
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic Utility of Gene Fusion Panel to Detect Gene Fusions in Fresh and Formalin-Fixed, Paraffin-Embedded Cancer Specimens.
Haley L; Parimi V; Jiang L; Pallavajjala A; Hardy M; Yonescu R; Morsberger L; Stinnett V; Long P; Zou YS; Gocke CD
J Mol Diagn; 2021 Oct; 23(10):1343-1358. PubMed ID: 34358677
[TBL] [Abstract][Full Text] [Related]
4. Comparison of RNA-Based Next-Generation Sequencing Assays for the Detection of NTRK Gene Fusions.
Park HJ; Baek I; Cheang G; Solomon JP; Song W
J Mol Diagn; 2021 Nov; 23(11):1443-1451. PubMed ID: 34756276
[TBL] [Abstract][Full Text] [Related]
5. The NAB2-STAT6 gene fusion in solitary fibrous tumor can be reliably detected by anchored multiplexed PCR for targeted next-generation sequencing.
Guseva NV; Tanas MR; Stence AA; Sompallae R; Schade JC; Bossler AD; Bellizzi AM; Ma D
Cancer Genet; 2016; 209(7-8):303-12. PubMed ID: 27292373
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic Utility of a Custom 34-Gene Anchored Multiplex PCR-Based Next-Generation Sequencing Fusion Panel for the Diagnosis of Bone and Soft Tissue Neoplasms With Identification of Novel USP6 Fusion Partners in Aneurysmal Bone Cysts.
Dermawan JK; Cheng YW; Tu ZJ; Meyer A; Habeeb O; Zou Y; Goldblum JR; Billings SD; Kilpatrick SE; Reith JD; Shurtleff SA; Farkas DH; Rubin BP; Azzato EM
Arch Pathol Lab Med; 2021 Jul; 145(7):851-863. PubMed ID: 33147323
[TBL] [Abstract][Full Text] [Related]
7. Anchored multiplex PCR for targeted next-generation sequencing reveals recurrent and novel USP6 fusions and upregulation of USP6 expression in aneurysmal bone cyst.
Guseva NV; Jaber O; Tanas MR; Stence AA; Sompallae R; Schade J; Fillman AN; Miller BJ; Bossler AD; Ma D
Genes Chromosomes Cancer; 2017 Apr; 56(4):266-277. PubMed ID: 27910166
[TBL] [Abstract][Full Text] [Related]
8. A Multiplexed Amplicon Approach for Detecting Gene Fusions by Next-Generation Sequencing.
Beadling C; Wald AI; Warrick A; Neff TL; Zhong S; Nikiforov YE; Corless CL; Nikiforova MN
J Mol Diagn; 2016 Mar; 18(2):165-75. PubMed ID: 26747586
[TBL] [Abstract][Full Text] [Related]
9. Detection of recurrent, rare, and novel gene fusions in patients with acute leukemia using next-generation sequencing approaches.
Kim B; Kim E; Lee ST; Cheong JW; Lyu CJ; Min YH; Choi JR
Hematol Oncol; 2020 Feb; 38(1):82-88. PubMed ID: 31875988
[TBL] [Abstract][Full Text] [Related]
10. Validation of a Next-Generation Sequencing Assay Targeting RNA for the Multiplexed Detection of Fusion Transcripts and Oncogenic Isoforms.
Sussman RT; Oran AR; Paolillo C; Lieberman D; Morrissette JJD; Rosenbaum JN
Arch Pathol Lab Med; 2020 Jan; 144(1):90-98. PubMed ID: 31211614
[TBL] [Abstract][Full Text] [Related]
11. A Targeted High-Throughput Next-Generation Sequencing Panel for Clinical Screening of Mutations, Gene Amplifications, and Fusions in Solid Tumors.
Luthra R; Patel KP; Routbort MJ; Broaddus RR; Yau J; Simien C; Chen W; Hatfield DZ; Medeiros LJ; Singh RR
J Mol Diagn; 2017 Mar; 19(2):255-264. PubMed ID: 28017569
[TBL] [Abstract][Full Text] [Related]
12. Detection of leukemia gene fusions by targeted RNA-sequencing in routine diagnostics.
Engvall M; Cahill N; Jonsson BI; Höglund M; Hallböök H; Cavelier L
BMC Med Genomics; 2020 Jul; 13(1):106. PubMed ID: 32727569
[TBL] [Abstract][Full Text] [Related]
13. Oncogenic Gene Fusion Detection Using Anchored Multiplex Polymerase Chain Reaction Followed by Next Generation Sequencing.
Seager M; Aisner DL; Davies KD
J Vis Exp; 2019 Jul; (149):. PubMed ID: 31329176
[TBL] [Abstract][Full Text] [Related]
14. Development and validation of an RNA sequencing panel for gene fusions in soft tissue sarcoma.
Hu W; Yuan L; Zhang X; Ni Y; Hong D; Wang Z; Li X; Ling Y; Zhang C; Deng W; Tian M; Ding R; Song C; Li J; Zhang X
Cancer Sci; 2022 May; 113(5):1843-1854. PubMed ID: 35238118
[TBL] [Abstract][Full Text] [Related]
15. Development and Validation of StrataNGS, a Multiplex PCR, Semiconductor Sequencing-Based Comprehensive Genomic Profiling Test.
Tomlins SA; Hovelson DH; Harms P; Drewery S; Falkner J; Fischer A; Hipp J; Kwiatkowski K; Lazo de la Vega L; Mitchell K; Reeder T; Siddiqui J; Vakil H; Johnson DB; Rhodes DR
J Mol Diagn; 2021 Nov; 23(11):1515-1533. PubMed ID: 34454112
[TBL] [Abstract][Full Text] [Related]
16. Detecting disease-defining gene fusions in unclassified round cell sarcomas using anchored multiplex PCR/targeted RNA next-generation sequencing-Molecular and clinicopathological characterization of 16 cases.
Mantilla JG; Ricciotti RW; Chen E; Hoch BL; Liu YJ
Genes Chromosomes Cancer; 2019 Oct; 58(10):713-722. PubMed ID: 31033080
[TBL] [Abstract][Full Text] [Related]
17. Detection of sarcoma fusions by a next-generation sequencing based-ligation-dependent multiplex RT-PCR assay.
Lanic MD; Le Loarer F; Rainville V; Sater V; Viennot M; Beaussire L; Viailly PJ; Angot E; Hostein I; Jardin F; Ruminy P; Laé M
Mod Pathol; 2022 May; 35(5):649-663. PubMed ID: 35075283
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous detection of lung fusions using a multiplex RT-PCR next generation sequencing-based approach: a multi-institutional research study.
Vaughn CP; Costa JL; Feilotter HE; Petraroli R; Bagai V; Rachiglio AM; Marino FZ; Tops B; Kurth HM; Sakai K; Mafficini A; Bastien RRL; Reiman A; Le Corre D; Boag A; Crocker S; Bihl M; Hirschmann A; Scarpa A; Machado JC; Blons H; Sheils O; Bramlett K; Ligtenberg MJL; Cree IA; Normanno N; Nishio K; Laurent-Puig P
BMC Cancer; 2018 Aug; 18(1):828. PubMed ID: 30115026
[TBL] [Abstract][Full Text] [Related]
19. Discovery of clinically relevant fusions in pediatric cancer.
LaHaye S; Fitch JR; Voytovich KJ; Herman AC; Kelly BJ; Lammi GE; Arbesfeld JA; Wijeratne S; Franklin SJ; Schieffer KM; Bir N; McGrath SD; Miller AR; Wetzel A; Miller KE; Bedrosian TA; Leraas K; Varga EA; Lee K; Gupta A; Setty B; Boué DR; Leonard JR; Finlay JL; Abdelbaki MS; Osorio DS; Koo SC; Koboldt DC; Wagner AH; Eisfeld AK; Mrózek K; Magrini V; Cottrell CE; Mardis ER; Wilson RK; White P
BMC Genomics; 2021 Dec; 22(1):872. PubMed ID: 34863095
[TBL] [Abstract][Full Text] [Related]
20. Assessment of BCOR Internal Tandem Duplications in Pediatric Cancers by Targeted RNA Sequencing.
Al-Ibraheemi A; Putra J; Tsai HK; Cano S; Lip V; Pinches RS; Restrepo T; Alexandrescu S; Janeway KA; Duraisamy S; Harris MH; Church AJ
J Mol Diagn; 2021 Oct; 23(10):1269-1278. PubMed ID: 34325058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
